Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
150%(3 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
4
80%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (80.0%)
Phase 41 (20.0%)

Trials by Status

terminated120%
completed240%
unknown120%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_2

Repurposing Tilmanocept for Cardiac Sarcoidosis

NCT07159074
terminatedphase_2

Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA

NCT04078191
completedphase_2

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

NCT03938636
unknownphase_4

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

NCT03199560
completedphase_2

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

NCT02201420

Clinical Trials (5)

Showing 5 of 5 trials
NCT07159074Phase 2

Repurposing Tilmanocept for Cardiac Sarcoidosis

Recruiting
NCT04078191Phase 2

Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA

Terminated
NCT03938636Phase 2

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

Completed
NCT03199560Phase 4

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

Unknown
NCT02201420Phase 2

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5